Kenneth Fischbeck

Branch Chief

National Institute of Neurological Disorders and Stroke

Position in Extended Committee - Preclinical Expert
Kenneth  Fischbeck

Kenneth is Chief of the Neurogenetics Branch at NINDS and a TREAT-NMD STAC member. He has experience with preclinical (animal) studies in various neuromuscular diseases including Duchenne muscular dystrophy, spinal muscular atrophy, and spinal and bulbar muscular atrophy (SBMA), and he has run clinical trials and biomarker studies in Duchenne muscular dystrophy, spinal muscular atrophy, Friedreich\'s ataxia, and SBMA.

He serves on advisory boards for voluntary organizations that are sponsoring similar therapeutics development initiatives, including the SMA Foundation, the ALS Association, and MDA Venture Philanthropy. He is also on the Data and Safety Monitoring Board for CINRG. He has experience with industrial therapeutics development from a sabbatical at Merck in 2005 and from subsequent service on advisory boards for Merck and Biogen Idec.

Neurogenetics Branch, NINDS
35-2A1000, 35 Convent Dr.
Bethesda, MD
20892-3705
United States of America


Call 1-301-435-9318
Website